Pharmacologic Treatment of Behavioral and Psychological Symptoms of Dementia


The cost for this online course is $35. The estimated time to complete this course is 1 hour and 45 minutes. Learners will be asked to complete an activity post-assessment with a passing score of 75%.

You must log in or create an account before enrolling in this educational activity. 

Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage.

Target Audience

Healthcare professionals.


  • Describe the natural history, prevalence, and presentation of behavioral and psychological symptoms of dementia (BPSD).
  • Develop a plan for assessing BPSD.
  • List the elements of a plan to manage BPSD, including behavioral, environmental, and pharmacological interventions.


Art Walaszek, MD
Vice Chair for Education and Faculty Development, Director of Psychiatry Residency Training, Geriatric Psychiatrist, and Professor of Psychiatry, University of Wisconsin School of Medicine & Public Health

Dr. Art Walaszek is a board-certified geriatric psychiatrist and Professor of Psychiatry at the University of Wisconsin School of Medicine and Public Health.  Dr. Walaszek is Vice Chair for Education and Faculty Development in the Department of Psychiatry. He is the past president of the American Association of Directors of Psychiatric Residency Training (AADPRT). Currently, he serves on the Psychiatry Review Committee of the Accreditation Council for Graduate Medical Education (ACGME). His research focuses on public health approaches to improving the care of people with dementia. Dr. Walaszek works with the Wisconsin Alzheimer’s Disease Research Center, Co-Leader of the Outreach, Recruitment, and Education Core, and the Wisconsin Alzheimer’s Institute, where he leads the Public Health Pillar.  Dr. Walaszek provides care to older adults with depression, anxiety, dementia, and other mental health conditions and teaches others to do the same.


Terms of Use and Privacy Policy

Recording date: November 5, 2022
Date of original release: November 30, 2022
Most recent review/update: November 30, 2022
Termination date: November 29, 2025

Course summary
Available credit: 
  • 1.75 AMA PRA Category 1 Credits
  • 1.75 AOA Category 1­B
  • 1.75 CE Contact Hour(s)
  • 1.75 IBON
Course opens: 
Course expires: 

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.75 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.75 continuing education contact hour(s). No partial credit awarded.​
  • Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 1.75 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 


The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.

  • Arthur Walaszek, MD - Speaker. Dr. Walaszek has no financial relationships to disclose but does intend to discuss the off-label use of a commercial product.


The information provided in this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 1.75 AMA PRA Category 1 Credits
  • 1.75 AOA Category 1­B
  • 1.75 CE Contact Hour(s)
  • 1.75 IBON


Please login or Create an Account to take this course.